Clinical Trials Logo

Covid19 clinical trials

View clinical trials related to Covid19.

Filter by:

NCT ID: NCT05215483 Completed - COVID-19 Clinical Trials

Availability and Advice on Test Uptake During the COVID-19 Pandemic: a Vignette Study.

Start date: November 11, 2021
Phase: N/A
Study type: Interventional

Lateral Flow Testing (LFT) use for COVID-19 related symptoms continues to rise, despite governmental advice to test at a test facility. In this study we investigate whether 1) adjusting the governmental testing advice will lead to a collective increase of people who test with COVID-19 symptoms and if this leads to a higher strategy sensitivity.

NCT ID: NCT05214196 Completed - COVID-19 Clinical Trials

The Efficacy of Oral Antiseptics Against COVID-19

Start date: September 1, 2021
Phase: Phase 4
Study type: Interventional

In a study conducted on 75 COVID-19 patients, the effect of SARS-CoV-2 on viral load was investigated as a result of the use of hypochlorous acid and povidone-iodine as an oral antiseptic.

NCT ID: NCT05213897 Completed - Covid-19 Clinical Trials

Clinical Performance Evaluation of SARS-CoV-2 (COVID-19) Antigen Assay in Point of Care Settings

Start date: January 27, 2022
Phase:
Study type: Observational

The purpose of this study is to evaluate the performance of Freedom For All Diagnostics, Inc.'s colloidal gold immune technology SARS-CoV-2 Antigen investigational assay when compared to a high-sensitivity Emergency Use Authorization (EUA) SARS-CoV-2 RT-PCR assay. The study will evaluate the accuracy in the intended use environment of the SARS-CoV-2 antigen assay when testing is conducted in a CLIA-waived setting (e.g., a physician's office or clinic) by non-laboratory personnel serving in a healthcare facility or setting.

NCT ID: NCT05212909 Completed - Anxiety Clinical Trials

Anxiety Level Assessment of Anesthesia Providers During COVID-19 Pandemic

Start date: August 1, 2020
Phase:
Study type: Observational

Healthcare providers caring for acutely ill or critical patients are exposed to constant stressful situations that can lead to psychiatric manifestations. Depression and anxiety derived from stressful work environments can negatively impact the ability to perform at full capacity directly affecting the quality of care the patients receive. The Severe Acute Respiratory Syndrome Coronavirus 2 infection created a sudden and deep crisis involving every sector worldwide not only affecting sick patients and the healthcare system but also the economy, politics, food, and drugs and social interactions. Hospital workers have experienced the crisis first-hand and have witnessed constant death, a decrease in personal protective equipment supplies, exposure to contracting the virus, risk of contagion to others, and overburdened hospital capacity. The aim of this study is to evaluate how the coronavirus disease 2019 (COVID-19) pandemic has affected healthcare workers. Specifically, to evaluate levels of anxiety and identify factors contributing to anxiety on faculty, residents, and nurse anesthetists in our institution.

NCT ID: NCT05212883 Completed - COVID-19 Clinical Trials

You and Me COVID Free

YMCF
Start date: November 15, 2021
Phase:
Study type: Observational

Observational, study that distributes rapid at-home, self-administered, SARS-CoV-2 antigen testing kits to households within pre-selected communities.

NCT ID: NCT05212870 Completed - Low Back Pain Clinical Trials

Investıgatıon Of The Effect Of The Pandemıc Process In Indıvıduals Wıth Chronıc Low Back And Neck Paın

Start date: November 22, 2021
Phase:
Study type: Observational

There are a limited number of studies examining the difficulty of reaching treatment related to the pandemic process and the general effects of the process in patients with chronic low back and neck pain. However, no study has been found that compares the effects of individuals actively carrying and not carrying the Covid-19 virus. For this reason, the aim of the study is to examine the effects of the pandemic process on the cognitive level, pain catastrophization, physical activity level and quality of life in individuals with chronic low back and neck pain.

NCT ID: NCT05212831 Completed - COVID-19 Clinical Trials

Portable Oxygen Concentrator (POC) Versus Standard of Care in Long-COVID: Randomized Crossover Exploratory Pilot Study.

RESTORE
Start date: June 8, 2022
Phase: N/A
Study type: Interventional

A prospective, open label, randomized, crossover, pilot, exploratory study to describe the effect of the Inogen One® G4 POC on brain hypoxia, peripheral oxygen saturation and cognitive function in adults with longterm- COVID.

NCT ID: NCT05212675 Completed - COVID-19 Clinical Trials

Short Daily Versus Conventional Hemodialysis for COVID-19 Patients

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Treatment of dialysis patients involved with COVID-19 with short daily hemodialysis has been supposed to improve short term outcome. It is unclear if short daily dialysis would optimize mortality or ICU admission in routine dialysis patients with COVID-19. Also the potential variants according with worse outcomes remain to be fully elucidated.

NCT ID: NCT05212480 Completed - SARS-CoV2 Infection Clinical Trials

Evaluation of the Efficacy and Safety of Zinc in Viral Infections

VIZIR
Start date: February 15, 2022
Phase: N/A
Study type: Interventional

The main objective of the clinical study is to evaluate the efficacy of Zinc supplementation in non-critically ill Covid-19 patients..

NCT ID: NCT05210179 Completed - COVID-19 Clinical Trials

Phase 2b Booster Vaccination (TURKOVAC) Against COVID-19

Start date: January 24, 2022
Phase: Phase 2
Study type: Interventional

This study is open-label, two arms, multi-centered, phase 2b clinical trial to determine the efficacy, safety, and immunogenicity of booster vaccination (TURKOVAC) against Covid-19. The primary aim of the study is to evaluate the efficacy of a booster dose of TURKOVAC vaccine administered to subjects who have passed at least 90 days and at most 240 days after the second dose of the first course of Comirnaty (Code name: BNT162b2) vaccine.